Official UK visa sponsor profile for Abzena (Cambridge) Limited in Cambridge, including current register status, route details, and public company data.
Abzena (Cambridge) Limited, registered in England and Wales under Reg: 05318448, was established in 2004 and currently maintains an active status. It operates as a limited company (Ltd). The company’s registered address is Babraham Research Campus, Babraham, Cambridge, CB22 3AT. Abzena functions as a fully integrated biologics and bioconjugates Contract Development and Manufacturing Organization (CDMO) plus Contract Research Organization (CRO). They provide services encompassing antibodies, antibody-drug conjugates (ADCs), antibody-organic chemical conjugates (AOCs), radiolabeled drug conjugates (RDCs), and vaccines, spanning from discovery through commercialization. The company’s key focus lies in other research and experimental development related to natural sciences and engineering. Company size is not explicitly specified on the website, but Abzena operates as a CDMO+CRO. Based on industry knowledge, Abzena is a medium-sized company. Financial records indicate accounts were prepared for the period ending 2023-12-31, with charges being false and the company not insolvent. Abzena utilizes the Skilled Worker visa route, holding a Worker (A rating). The company has no international presence.
Official UK visa sponsor profile for Abzena (Cambridge) Limited in Cambridge, including current register status, route details, and public company data.
Abzena (Cambridge) Limited, registered in England and Wales under Reg: 05318448, was established in 2004 and currently maintains an active status. It operates as a limited company (Ltd). The company’s registered address is Babraham Research Campus, Babraham, Cambridge, CB22 3AT. Abzena functions as a fully integrated biologics and bioconjugates Contract Development and Manufacturing Organization (CDMO) plus Contract Research Organization (CRO). They provide services encompassing antibodies, antibody-drug conjugates (ADCs), antibody-organic chemical conjugates (AOCs), radiolabeled drug conjugates (RDCs), and vaccines, spanning from discovery through commercialization. The company’s key focus lies in other research and experimental development related to natural sciences and engineering. Company size is not explicitly specified on the website, but Abzena operates as a CDMO+CRO. Based on industry knowledge, Abzena is a medium-sized company. Financial records indicate accounts were prepared for the period ending 2023-12-31, with charges being false and the company not insolvent. Abzena utilizes the Skilled Worker visa route, holding a Worker (A rating). The company has no international presence.
Yes, Abzena (Cambridge) Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Abzena (Cambridge) Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Abzena (Cambridge) Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Abzena (Cambridge) Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.